Published in Gut on July 01, 1993
Clinical results of the transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of variceal bleeding. Korean J Intern Med (2000) 0.78
Transjugular intrahepatic portosystemic stent shunts. Gut (1994) 0.75
Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis. Ann Surg (1998) 0.75
Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet (1990) 3.37
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology (1990) 2.02
Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet (1983) 2.01
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet (1991) 1.88
Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med (1992) 1.80
Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med (1990) 1.75
Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding. Preliminary report of a prospective, randomized trial. Ann Surg (1986) 1.62
Transjugular portal venography and radiologic portacaval shunt: an experimental study. Radiology (1969) 1.52
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology (1985) 1.35
N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy. Endoscopy (1987) 1.31
Percutaneous transjugular portosystemic shunt. JAMA (1991) 1.25
Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology (1990) 1.19
Effect of a prior portasystemic shunt on subsequent liver transplantation. Ann Surg (1989) 1.12
A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology (1986) 1.11
[The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method]. Radiologe (1989) 1.11
A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med (1989) 1.10
Results of a randomized trial of end-to-side portacaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding. Gastroenterology (1986) 1.08
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Transjugular intrahepatic portacaval shunt. An experimental work. Am J Surg (1971) 1.03
Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter. Can Med Assoc J (1982) 1.01
Controlled clinical trial of injection sclerotherapy for active variceal bleeding. Hepatology (1989) 0.98
Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience. AJR Am J Roentgenol (1983) 0.92
Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial. Gastroenterology (1990) 0.89
Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents. Radiology (1987) 0.88
Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension. AJR Am J Roentgenol (1986) 0.87
Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol (1985) 0.83
New non-operative treatment for variceal haemorrhage. Lancet (1989) 0.83
Percutaneous intrahepatic portosystemic shunt created via a femoral vein approach. Radiology (1991) 0.79
Endoscopy in gastrointestinal bleeding. Lancet (1974) 4.02
Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet (1990) 3.37
Should methionine be added to every paracetamol tablet? BMJ (1997) 3.33
The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut (2005) 2.82
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut (1998) 2.45
Hepatotoxicity of herbal remedies. BMJ (1989) 2.37
UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut (2000) 2.33
Postmortem study of the frequency of gallstones in patients with cirrhosis of the liver. Gut (1969) 2.31
Quantifying the disease impact of alcohol with ARDI software. Public Health Rep (1991) 2.13
Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut (1976) 2.10
Transjugular intrahepatic portosystemic stent-shunts: a new option in portal hypertension. Br J Hosp Med (1993) 2.04
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet (1999) 1.89
Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.87
Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol (1995) 1.84
Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care (2001) 1.82
The normal and abnormal pancreatic scan. Q J Med (1968) 1.74
The polymath practitioners. Thomas Beale, M.D. (1807-1849) and Frederick Debell Bennett, M.D. (1806-1859). Practitioner (1976) 1.72
Primary biliary cirrhosis and coeliac disease: an association? Lancet (1978) 1.70
Serum bile acids in the diagnosis of hepatobiliary disease. Gut (1977) 1.63
The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J (1999) 1.63
Intraluminal bile-salt deficiency in the pathogenesis of steatorrhoea. Lancet (1969) 1.58
Hepatic encephalopathy and ascites. Lancet (1997) 1.57
Biliary mucous substances in dihydrocholesterol-induced cholelithiasis. Gastroenterology (1969) 1.57
Randomised clinical study: comparison of acceptability, patient tolerance, cardiac stress and endoscopic views in transnasal and transoral endoscopy under local anaesthetic. Aliment Pharmacol Ther (2014) 1.54
Diagnosis of inflammatory bowel disease: an international multicentre scoring system. Br Med J (Clin Res Ed) (1982) 1.53
A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol (1995) 1.52
A cross-site vascular radiology on-call service: the Manchester experience. Clin Radiol (2005) 1.51
Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther (2003) 1.49
TIPSS 10 years on. Gut (2000) 1.48
Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol (1997) 1.48
The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation (2000) 1.47
A study of symptomatic and "silent" gallstone. Scand J Gastroenterol (1968) 1.47
Chronic pancreatitis in England: a changing picture? Br Med J (1974) 1.46
Death in acute upper gastrointestinal bleeding. Can endoscopy reduce mortality? Lancet (1976) 1.43
Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: Scarring. Arch Dis Child (1995) 1.43
Hepatotoxicity of sodium stibogluconate in leishmaniasis. Lancet (1993) 1.42
Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 1: Reflux. Arch Dis Child (1995) 1.41
Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms. Ann Surg (2001) 1.41
Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology (1995) 1.40
The sequential organ failure assessment (SOFA) score is an effective triage marker following staggered paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther (2012) 1.40
The hands in alcoholic liver disease. Am J Gastroenterol (1991) 1.39
A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology (1997) 1.39
Normal venous circulation of the gastroesophageal junction. A route to understanding varices. Gastroenterology (1987) 1.39
Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab (2000) 1.38
Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts. Aliment Pharmacol Ther (2008) 1.38
Non-organic gastrointestinal illness: a medical and psychiatric study. Br J Psychiatry (1980) 1.37
Gas-liquid chromatographic assay of serum bile acids. Anal Biochem (1977) 1.36
Recurrent varicose veins: a varicographic analysis leading to a new practical classification. Br J Surg (1995) 1.33
Mucous substances and viscosity of normal and pathological human bile. Gastroenterology (1965) 1.32
Alterations in hepatic bile composition after cholecystectomy. Gastroenterology (1972) 1.30
Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol (1981) 1.27
The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases. Scand J Gastroenterol Suppl (1984) 1.26
Brides of quietness: silent gall stones. Br Med J (Clin Res Ed) (1983) 1.25
The medical treatment of gallstones. Annu Rev Med (1980) 1.24
Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution. Lancet (1978) 1.22
Clinical value of bile salt tests in anicteric liver disease. Gut (1981) 1.22
Imaging procedures to diagnose gall bladder disease. Br Med J (Clin Res Ed) (1984) 1.21
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut (2000) 1.20
Collagenous colitis associated with small intestinal villous atrophy. Gut (1986) 1.19
Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer (2003) 1.19
Gallstone formation. Lancet (1971) 1.19
Changes in the ultrastructure of gall bladder epithelium in rabbits with experimental gallstones. Gut (1968) 1.17
Radioselenium in duodenal aspirate as an assessment of pancreatic exocrine function. Br Med J (1971) 1.16
Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology (2000) 1.14
Diminished micellar phase lipid in patients with chronic nonalcoholic liver disease and steatorrhea. Gastroenterology (1970) 1.14
Evaluation of the Lundh test in the diagnosis of pancreatic disease. J Clin Pathol (1972) 1.13
Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol (1996) 1.12
Assessment of the 14C-glycocholic acid breath test. Br Med J (1973) 1.11
UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients. Aliment Pharmacol Ther (2012) 1.10
Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut (1997) 1.09
The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut (2008) 1.08
Value of hypotonic duodenography as an adjunct to pancreatic scanning. Gut (1969) 1.07
Transjugular intrahepatic portosystemic stent shunt (TIPSS): early clinical experience. Clin Radiol (1992) 1.07
Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet (1970) 1.07
Macromolecular assemblies of lipid in bile. Biochim Biophys Acta (1970) 1.07
Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J (1977) 1.06
Serum bile acids in hepatobiliary disease. Gut (1978) 1.06
Review article: the current management of acute liver failure. Aliment Pharmacol Ther (2009) 1.06
Small intestinal permeability in pediatric clinical practice. J Pediatr Gastroenterol Nutr (1988) 1.05
Duodenal involvement in Gardner's syndrome. Gut (1972) 1.04
Screening for hepatocellular carcinoma. Eur J Gastroenterol Hepatol (1996) 1.04